Please ensure Javascript is enabled for purposes of website accessibility

Why Landec Stock Crashed on Thursday

By John Ballard – Sep 30, 2021 at 12:53PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company failed to meet earnings expectations, causing a sharp sell-off.

What happened

Shares of Landec (LNDC -1.00%) plunged after the company delivered disappointing earnings results for the fiscal first quarter of 2022. The stock was trading down 10.5% as of 11:28 a.m. EDT on Thursday.

The natural foods producer reported a revenue decline of 5.5% year over year, which was roughly in line with analyst estimates. However, the bottom line performed worse than expected, with Landec reporting an adjusted net loss of $0.23 per share, compared to expectations for a narrower net loss of $0.11. 

A gardener inspecting a plant in a large greenhouse.

Image source: Getty Images.

So what

The Curation Foods business was the main culprit, which posted a 6% decline in revenue and a 129% drop in earnings before interest, taxes, depreciation, and amortization (EBITDA). Management has been simplifying operations at Curation Foods to improve profitability in that segment, but it continues to be an anchor on the company overall. 

While management was pleased with Curation's gross profit margin of 11%, it overshadowed EBITDA growth of 57% in the Lifecore biomedical segment. As Lifecore President James Hall explained on the earnings call, the business is a "beneficiary of the significant trends toward outsourcing of new drug development. Hall added that Lifecore's "syringe and bio-filling capabilities align perfectly with the powerful trends in new injectable drug applications that are utilizing those modalities." 

Now what

Management is sticking with its full-year outlook, despite the recent earnings shortfall. The company is calling for revenue from continuing operations, which excludes the strategic contraction of the Curation Foods business, to be flat to up 1.8% in fiscal 2022, while adjusted EBITDA should improve between 6% to 13% year over year. 

Going forward, CEO Albert Bolles sees a "nimbler organization," which translates to better margins. While there is more work to do, Bolles said, "We have a solid foundation at both our businesses and expect to drive more consistent results going forward as we work toward delivering enhanced shareholder value." 

John Ballard has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Stocks Mentioned

Landec Stock Quote
$7.96 (-1.00%) $0.08

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.